focus
Previous article:
What does generative AI mean for health care? We asked experts
Next article: Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study
Next article: Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study
entertainment
hotspot
-
Medicare coverage of Wegovy, once blocked, now looks possible
2025-08-12 08:07 -
Being 'nonadherent' patient made me a more empathetic doctor
2025-08-12 07:28 -
Prescription digital therapeutics are key to pharma’s future
2025-08-12 07:25 -
The biotech scorecard for Q3: 15 stock
2025-08-12 06:55 -
John Green on his newest strategy for fighting tuberculosis
2025-08-12 06:50 -
STAT wants to know your pick for a great summer read or listen
2025-08-12 06:03